for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Davita Inc

DVA.N

Latest Trade

98.84USD

Change

0.48(+0.49%)

Volume

515,961

Today's Range

97.79

 - 

99.70

52 Week Range

94.39

 - 

136.44

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
98.36
Open
98.64
Volume
515,961
3M AVG Volume
17.06
Today's High
99.70
Today's Low
97.79
52 Week High
136.44
52 Week Low
94.39
Shares Out (MIL)
101.90
Market Cap (MIL)
10,022.88
Forward P/E
11.10
Dividend (Yield %)
--

Next Event

Q4 2021 DaVita Inc Earnings Release

Latest Developments

More

Davita Inc Reports Q3 Earnings Per Share of $2.36 From Continuing Operations

Berkshire Hathaway stake in DaVita rises to 34.4%, share count unchanged

Davita Inc Reports Q2 Revenue Of $2.917 Bln

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Davita Inc

DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD). In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.

Industry

Healthcare Facilities

Contact Info

2000 16th St

DENVER, CO

80202-5158

United States

+1.310.5362668

https://www.davita.com/

Executive Leadership

Pamela M. Arway

Independent Chairman of the Board

Javier J. Rodriguez

Chief Executive Officer, Director

Joel Ackerman

Chief Financial Officer, Treasurer

John D. Winstel

Chief Accounting Officer

James O. Hearty

Chief Compliance Officer

Key Stats

3.09 mean rating - 11 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

11.4K

2019

11.4K

2020

11.6K

2021(E)

11.6K
EPS (USD)

2018

3.570

2019

5.400

2020

7.260

2021(E)

8.862
Price To Earnings (TTM)
11.23
Price To Sales (TTM)
0.87
Price To Book (MRQ)
8.83
Price To Cash Flow (TTM)
5.32
Total Debt To Equity (MRQ)
777.57
LT Debt To Equity (MRQ)
763.06
Return on Investment (TTM)
9.10
Return on Equity (TTM)
7.01

Latest News

Latest News

U.S. FTC to restrict future deals for firms that pursue 'anticompetitive mergers'

The U.S. Federal Trade Commission said on Monday it was restoring its practice of requiring companies that previously pursued an anticompetitive deal to get prior approval for certain future transactions, even very small ones.

DaVita, former CEO indicted on labor market collusion charges

Dialysis provider DaVita and its former CEO Kent Thiry were indicted by a federal grand jury in Denver on charges they conspired with competitors not to hire each other's key employees, the U.S. Justice Department said on Thursday.

BRIEF-Davita Announces Pricing Of $1.75 Bln Senior Notes Offering

* DAVITA INC. ANNOUNCES PRICING OF $1.75 BILLION SENIOR NOTES OFFERING

BRIEF-Davita Inc. Announces Offering Of $1.75 Billion Senior Notes

* DAVITA INC. ANNOUNCES OFFERING OF $1.75 BILLION SENIOR NOTES

BRIEF-Davita Reports Q1 Results

* Q1 ADJUSTED EARNINGS PER SHARE $1.83 FROM CONTINUING OPERATIONS

BRIEF-DaVita Launches Venture Group To Accelerate Advancements In Kidney Care

* DAVITA LAUNCHES VENTURE GROUP TO ACCELERATE ADVANCEMENTS IN KIDNEY CARE Source text for Eikon: Further company coverage:

BRIEF-Davita Inc. Provides Commentary On COVID-19 Pandemic

* DAVITA INC - SCREENING EVERY PERSON WHO ENTERS A DAVITA CENTER FOR SYMPTOMS AND EXPOSURE TO COVID-19

BRIEF-Davita Kidney Care Says Plans To Hire At Least 15,000 New Employees Throughout 2020

* DAVITA KIDNEY CARE SAYS PLANS TO HIRE AT LEAST 15,000 NEW EMPLOYEES THROUGHOUT 2020 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

Fresenius Medical Care working with dialysis providers in U.S. to tackle coronavirus

Fresenius Medical Care (FMC) on Wednesday said it was working with other dialysis providers to provide care in isolation for people with kidney problems in the United States who are or may be infected with coronavirus.

BRIEF-Davita Kidney Care To Give U.S. Employees An Extra $100 Each Week

* DAVITA KIDNEY CARE - ANNOUNCED IT IS GIVING U.S. EMPLOYEES, KNOWN AS TEAMMATES, AN EXTRA $100 EACH WEEK Source text for Eikon: Further company coverage:

DaVita, Fresenius used kidney disease charity to pay kickbacks - lawsuit

Dialysis providers DaVita Inc and Fresenius Medical Care violated an anti-kickback law by contributing to a charity that helps kidney disease patients afford treatment that then steered business to them, a newly unsealed whistleblower lawsuit alleges.

UnitedHealth gets FTC approval for DaVita unit purchase

UnitedHealth Group Inc won anti-trust approval to buy DaVita Inc's primary and urgent care unit for $4.3 billion, the Federal Trade Commission said on Wednesday.

U.S. FTC approves UnitedHealth's proposed purchase of DaVita unit

UnitedHealth Group Inc won antitrust approval to buy DaVita Inc's primary and urgent care unit for $4.3 billion, the Federal Trade Commission said on Wednesday. (Reporting by Diane Bartz Editing by Leslie Adler)

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up